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Abstract
Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a recently described life-threatening autoimmune
disorder associated with a characteristic multi-stage neuropsychiatric syndrome. Although it is known that the majority of
patients experience neuropsychological disturbance post-treatment, some aspects of the cognitive proﬁle remain unclear.
Methods: This study sought to investigate patterns of cognitive functioning in a sample of anti-NMDAR encephalitis patients.
Seven (6F:1M; mean age, 26.4 years; range, 16–37 years) treated patients completed a comprehensive set of neurocognitive and
social functioning measures. Performance was analyzed using normative data (where available), and comparison with matched
controls (10F:4M; mean age, 25.8 years; range, 16–38 years). Results: Individual cognitive proﬁles ranged from within normal
limits to extensive dysfunction. Relative to controls, the patient group’s performance was affected in the domains of verbal/
visual memory, working memory, attention, processing speed, executive functioning, and social cognition. The patient group
also reported signiﬁcantly higher levels of anxiety compared to controls. Conclusions: These results add to the accumulating
evidence that neurocognitive deﬁcits, consistent with the distribution and functions of the NMDAR system can persist during
recovery from anti-NMDAR encephalitis. This is the ﬁrst study to provide evidence of performance decrements on measures of
social cognition, including some involving theory of mind. (JINS, 2016, 22, 828–838)
Keywords: Anti-N-methyl-D-aspartate receptor encephalitis, Cognition disorders, Neuropsychology, Social behavior,
Theory of mind, Treatment outcome
INTRODUCTION
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is
a recently described autoimmune disease associated with
NMDAR antibodies and a multi-stage neuropsychiatric
syndrome (Dalmau et al., 2008; Dalmau, Lancaster,
Martinez-Hernandez, Rosenfeld, & Balice-Gordon, 2011;
Dalmau et al., 2007). Early symptoms are predominantly
psychiatric, however, the syndrome progresses to include
cognitive deﬁcits, seizures, movement disorders, autonomic
instability, and coma (Dalmau et al., 2011; Irani et al., 2010).
Patients are typically females of reproductive age, although
male, pediatric, and older adult patients have been reported
(Dalmau & Rosenfeld, 2014). Anti-NMDAR encephalitis is
paraneoplastic in approximately half of cases, although tumor
detection varies by age, gender, and ethnicity (Dalmau et al.,
2011; Dalmau & Rosenfeld, 2014).
Compelling evidence suggests an antibody-mediated
disease pathogenesis. Antibodies reduce receptor density
from synaptic sites, leading to characteristic physiological,
behavioral, and cognitive disturbance (Hughes et al., 2010;
Moscato et al., 2010, 2013). Congruent with genetic and
pharmacological models, the loss of synaptic NMDAR
functions accounts for symptom presentation and course,
given the roles of this system in excitatory neurotrans-
mission, and synaptic modiﬁcation (Dalmau et al., 2011;
Waxman & Lynch, 2005). Increases and decreases in
synaptic efﬁcacy associated with NMDAR-facilitated
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induction of long-term potentiation and depression are the
likely cellular correlates of learning and memory (Bliss &
Collingridge, 1993; Hunt & Castillo, 2012).
Antibody effects are reversible with treatment (Moscato
et al., 2010), and positive outcomes are seen in approximately
81% of patients (Titulaer et al., 2013). Declining antibody titers
correlate with symptom improvements (Dalmau et al., 2008,
2011). However, the condition is life threatening in the acute
stages and relapses represent a 12% risk within 2 years (Dalmau
et al., 2011; Titulaer et al., 2013). Early immunotherapy and
tumor resection are considered favorable prognostic factors
(Titulaer et al., 2013). Paraneoplastic anti-NMDAR encephalitis
is thought to be particularly treatment-responsive (Dalmau et al.,
2008, 2011; Florance et al., 2009), but this is not always the case
(Irani et al., 2010; Titulaer et al., 2013).
Acute-phase cognitive deﬁcits typically involve short-term
memory dysfunction, and language disintegration (Dalmau et al.,
2011; Florance et al., 2009; Irani et al., 2010). Deﬁcits in
memory and executive functioning have also been shown to
represent a major long-term morbidity of anti-NMDAR ence-
phalitis (Finke et al., 2012). However, additional high-quality
neuropsychological studies with this population are necessary to
clarify the nature of cognitive deﬁcits, particularly with respect to
sub-processes within major cognitive domains such as memory
and executive functioning.
Social cognition following anti-NMDAR encephalitis has
only been investigated in one study of two patients (Bach,
2014). Social cognition “difﬁculties” were reported, however,
the extent of deﬁcits was unclear. Anecdotal reports that
social functions recover late and that children can develop a
phenotype resembling autism suggests more comprehensive
evaluation of these abilities is warranted (Creten et al., 2011;
Dalmau et al., 2011). This exploratory study aims to investigate
patterns of cognitive functioning (including social cognition) in
patients treated for anti-NMDAR encephalitis.
MATERIALS AND METHODS
Participants and Procedure
Seven treated anti-NMDAR encephalitis patients (six females)
aged 16–37 years (M = 26.42; SD = 8.54) were recruited
via Queensland-based physicians. Patient performance was
compared to a sample of 14 control participants (10 females)
aged between 16 and 38 years (M = 25.85; SD = 7.71)
without signiﬁcant psychiatric or neurological histories.
Control participants were carefully selected to match the patient
group on the basis of age, gender and education level. All were
assessed by a Clinical Neuropsychologist trainee (G.M.) under
supervision (G.R. and D.S.). Clinical variables were sourced
from medical records, with additional detail provided by
patients or physicians.
This study received ethical clearance from the Human
Research Ethics Committees at both the Royal Brisbane and
Women’s Hospital and The University of Queensland. All
participants provided informed written consent.
Clinical and Functional Variables
Clinical variables included: (1) demographics (age, gender);
(2) time elapsed between acute treatment and neuropsychological
testing; (3) nature of treatment; (4) history of relapses;
(5) disease etiology; (6) history of psychiatric admissions; and
(7) serum/cerebrospinal ﬂuid (CSF) antibody testing results at
diagnosis and most recent follow-up.
Functional outcomes were evaluated at the time of
neuropsychological testing using the modiﬁed Rankin
Scale (mRS; Patel et al., 2012). Previous anti-NMDAR
encephalitis research has used ordinal mRS bands to classify
outcomes (Dalmau et al., 2008; Titulaer et al., 2013), which
were adopted by the present study (“good” = 0 – 2;
“poor”> 2). The Hospital Anxiety and Depression Scale
(Snaith & Zigmond, 1994) is a 14-item self-report measure
that was administered to evaluate the severity of symptoms of
anxiety and depression. Scores of ≥8 and ≥11 are considered
suggestive of possible and probable caseness, respectively
(Snaith & Zigmond, 1994). Patients also subjectively rated
their recovery on a scale from 1 (worst) to 10 (best).
Neuropsychological Assessment
Participants underwent comprehensive neuropsychological
testing, which included standardized measures of intellectual
functioning (premorbid - Test of Premorbid Functioning;
Wechsler, 2009; current - Wechsler Abbreviated Scale of
Intelligence, 2nd Edition; Wechsler & Zhou, 2011), episodic
memory (visual - Rey Complex Figure Test; Meyers &
Meyers, 1996; verbal - selected Wechsler Memory Scale,
4th Edition subtests [Logical Memory and Verbal Paired
Associates tasks]; Wechsler, Holdnack, & Whipple Drozdick,
2009), semantic memory (Pyramids and Palm Trees Test;
Howard & Patterson, 1992), language (spontaneous speech -
Cookie Theft Scene; Goodglass, Kaplan, & Barresi, 2000;
nominal functions - Graded Naming Test; Warrington, 1997),
auditory short-term and working memory (Wechsler Adult
Intelligence Scale, 4th edition [WAIS-IV], Digit Span subtest;
Wechsler, Coalson, & Engi Raiford, 2008), attention and
processing speed (selected Delis-Kaplan Executive Function
System [D-KEFS; Motor Speed, Visual Scanning, Number
Sequencing, and Letter Sequencing trials of the Trail Making
Test, andColourNaming andWordReading trials of the Colour-
Word Interference Test] and WAIS-IV subtests; [Digit Span]
Delis, Kaplan, & Kramer, 2001; Wechsler et al., 2008), and
executive functioning (Hayling Sentence Completion Test and
selected D-KEFS measures of initiation, response inhibition,
cognitive ﬂexibility, planning, problem solving, verbal ﬂuency,
abstraction and rule learning, including the Trail Making, Tower,
Proverbs, Verbal Fluency, and Colour Word Interference tests;
Burgess & Shallice, 1997; Delis et al., 2001).
The Hayling Sentence Completion Test (Burgess &
Shallice, 1997) was designed to assess verbal initiation and
inhibition in the same task. A sentence with the last word
omitted (e.g., The captain stayed with the sinking…) is orally
presented and individuals are asked to complete it either
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meaningfully (…ship), measuring initiation, or with an
unconnected word (e.g.,…elephant), measuring inhibition of
a prepotent response. Four scores are derived based on the
response time (RT) to produce a connected word (Initiation
RT) or an unconnected word (Suppression RT), the errors
produced instead of an unrelated word (Suppression Errors),
and a combination of RTs and Errors (Overall Score). All
four scores are sensitive to frontal lobe damage (Robinson
et al., 2015).
Experimental Attention Battery
The Sustained Attention to Response Task (SART;
Robertson, Manly, Andrade, Baddeley, & Yiend, 1997) is a
theoretically based measure of sustained attention and
cognitive control. Two-hundred twenty-ﬁve digits from 1 to
9 (25 of each number) were visually presented to participants
over 4.3-min. Numbers were displayed for 250ms, and were
followed by a 900-ms mask (an “X”). Participants pressed the
space bar to each digit, except when a target number speciﬁed
at the start of the task was randomly displayed, which
signaled responses should be withheld. Participants were
instructed to allocate equal priority to accuracy and speed.
Before the task, participants completed a practice trial
consisting of 18 digit presentations, two of which were
targets. Errors of commission (responses on no-go trials) and
omission (non-response on go-trials) were used as measures
of failures in response inhibition (commission errors only)
and sustained attention. Reaction times of all key presses
were collected to investigate variability in response latencies
indicative of lapsing attention.
Participants completed a psychological refractory period
(PRP; Pashler, 1994) paradigm to investigate dual task
performance. This task required participants to complete two
serially presented tasks as quickly and accurately as possible.
The two tasks were separated by a variable time interval,
known as the stimulus onset asynchrony (SOA), which was
either short (200ms) or long (1000ms). Task 1 required
responses (rapid key presses) to one of two letters (e.g., H vs. S)
using one of two keys. This was immediately followed by task
2, which required a response to one of two colored circles (e.g.,
red vs. blue) using one of two keys. Three blocks comprised of
60 individual trials each were completed, with the stimuli
changing between blocks (Block 1: “H” and “S,” red and blue;
Block 2: “E” and “D,” green and yellow; Block 3: “J” and “K”,
purple and orange). Practice blocks preceded each condition,
where participants were provided with feedback regarding
accuracy. Outcome measures included average reaction time
and overall accuracy across short SOA and long SOA trials.
Social Cognition Assessment
Four measures investigated aspects of social cognition,
including: (1) mental state decoding, also known as theory of
mind (ToM); (2) emotion recognition; and (3) processing
behavioral appropriateness across social contexts.
Three tasks (advanced ToM, emotion attribution and social
situation tasks) were developed and used with adults with
neurological conditions (Baird et al., 2006; Blair & Cipolotti,
2000; Heims, Critchley, Dolan, Mathias, & Cipolotti, 2004;
van Harskamp, Rudge, & Cipolotti, 2005) and acquired
psychopathy (Blair & Cipolotti, 2000). Full details and
examples of these three tasks are given in the original studies;
however, we provide brief details below.
Advanced ToM Task
In this task participants read 15 stories depicting social sce-
narios, and answer questions requiring interpretation and
justiﬁcation of the protagonist’s behavior. Three scores
index situation comprehension, and the use of mental state
and physical information during interpretation. An example
story is as follows: “Daniel and Ian see Mrs. Thompson
coming out of the hairdressers one day. She looks a bit funny
because the hairdresser has cut her hair too short. Daniel
says to Ian: “She must have been in a ﬁght with a
lawnmower!” After reading each story, participants are asked
a “comprehension question” where they are required to
demonstrate whether or not they understood important
subtleties within the story (e.g., “is it true what Daniel
said?”). Participants are then asked to justify in their own
words why the protagonist may have behaved in that way or
made such a statement (e.g., “why does he say this?”). These
responses are then evaluated with respect to whether the
participant included mental state information in their
justiﬁcation (e.g., “Daniel thinks her hair looks funny and he
is making a joke about how bad she looks”), or relied upon
physical material in their explanation (e.g., “because her hair
is too short.”).
Emotion Attribution Task
Participants read 75 short stories describing emotional
situations. Their task is to specify an emotion describing how
the character might feel in that scenario. Stories were
designed to elicit attributions of happiness, sadness, anger,
fear, and embarrassment, with 15 items for each emotion. For
example “Cathy has received some exam results; she has
done very well” is designed to elicit happiness.
Social Situations Task
Participants read 39 short stories involving behaviors that can
be classiﬁed as conventional or social violations in the nar-
rative context. They allocate a score from “A” (fairly normal
behavior) to “D” (shocking behavior). Seventeen normative
behaviors (“A” = correct) and 20 violations (“B”–“D” =
correct) were presented. Three scores were derived. The ﬁrst
two scores were the number of normative situations and
violations correctly identiﬁed, with higher scores indicating
greater accuracy. For each violation correctly identiﬁed,
responses were then numerically scored to reﬂect the extent to
which they perceived the behavior to be inappropriate
(e.g., B = 1, C = 2, D = 3). These were summed to
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calculate the third score, which was an overall violation
severity score. Higher scores on this measure indicated that
the person perceived the social violations to be more
shocking.
Reading the Mind in the Eyes Task
Originally developed to assess adult ToM competence
(Baron-Cohen, Jolliffe, Mortimore, & Robertson, 1997), this
task involves viewing 36 photographs of the eye regions of
people acting out psychological states. Participants decide
which of four emotions of the same valence best represents
what the person is thinking or feeling. Performance
differentiates non-clinical samples from various groups
with known social functioning deﬁcits including people
with schizophrenia (Craig, Hatton, Craig, & Bentall, 2004;
Kettle, O’Brien-Simpson, & Allen, 2008; Murphy, 2006),
and autism spectrum disorders (Baron-Cohen et al., 1997;
Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001).
Statistical Analyses
Due to the exploratory nature of the current study, no
correction for multiple comparisons was made during
statistical analyses.
Group Analyses
To compare the patient and control samples on potentially
confounding demographic variables, a series of chi-square
and independent t tests were conducted. Independent t tests
and non-parametric Mann-Whitney U tests examined
differences between groups with respect to testing scores.
Non-parametric tests were used where test assumptions were
violated. An alpha value of .05 was consistently adopted as
the signiﬁcance threshold (two-tailed).
Case Series Analyses
To characterize each patient’s cognitive proﬁle, analyses
were also conducted on individual scores. Deﬁcits were
recorded on standardized measures where performance fell at
or below the 10th percentile. To account for problems
associated with small sample size, modiﬁed t test analyses
compared individual patient and control group scores on
measures without normative data (Crawford & Garthwaite,
2002; Crawford & Howell, 1998).
RESULTS
Patient Characteristics
Patient and control group demographics are summarized
in Table 1. Patient clinical information is summarized in
Table 2. Neurocognitive and social function was assessed
in all patients outside the acute disease phase. No patient
exhibited abnormal cerebral MRI ﬁndings (Siemens, 1.5 Tesla)
before the initiation of immunotherapy. No abnormalities
were detected on T1, T2, ﬂuid attenuated inversion recovery
(FLAIR) or diffusion weighted imaging (DWI) sequences.
Electroencephalogram was abnormal in six cases (all except
P1) with ﬁndings suggesting diffuse disorders of cortical
function. Two patients who were CSF positive at diagnosis
did not require further testing following dramatic clinical
response (P2, P7). Persistent serum antibodies unchanged
in intensity from ﬁrst testing were reported in three patients
(P1, P4, P5).
Paraneoplastic etiologies were identiﬁed in two patients
(P3, P7) following pelvic examination and either pelvic MRI
or ultrasound (or both). Another patient (P4) underwent
thymectomy. Four patients (P2, P3, P6, P7) received
treatment within a month of symptom onset, and had not
relapsed. The remaining three patients (P1, P4, P5) had
lengthy psychiatric histories and comparatively poorer
response to immunotherapy. Two of these cases (P1 and P5)
presented with historical symptoms potentially indicative
of neurological disturbance before the characterization of
anti-NMDAR encephalitis (e.g., signiﬁcant catatonia, seizure
activity, multi-system organ dysfunction). Nonetheless,
without access to serum or CSF samples for retrospective
antibody analysis we could not deﬁnitively conclude
that these patients were presenting with anti-NMDAR
encephalitis before the characterization of the disease.
It was challenging to reliably estimate the duration of
untreated illness in these cases.
Problems with memory, fatigue, anxiety, emotional
lability, and personality changes were the most commonly
Table 1. Summary of demographic variables for patients and control participants
Patient group (n= 7) Control group (n= 14)
M SD M SD Test statistic Signiﬁcance
Age (years) 26.42 8.54 25.85 7.71 t(19)= .155 p= .879
Gender (%F) 85.71 — 71.42 — χ2 (1)= .525 p= .624
Education (years) 13.50 1.97 13.46 1.33 t(19)= .049 p= .961
Handedness (R:L) 6:1 — 13:1 — χ2 (1)= .276 p= 1.000
Premorbid IQ 98.42 8.26 108.35 9.36 U= 15.00 p< .011*
Current IQ 102.57 6.97 109.71 8.93 t(19)= −1.845 p= .081
Note. F= female, IQ= intellectual quotient; L= left; M=male; R= right.
* p < .05.
Anti-NMDAR encephalitis cognitive outcomes 831
https://doi.org/10.1017/S1355617716000679
Downloaded from https://www.cambridge.org/core. UQ Library, on 07 Aug 2017 at 01:04:32, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
Table 2. Patient clinical and demographic information
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
Gender F F F M F F F
Age 37 19 28 19 36 30 16
Tumor No No R ovarian teratoma No, but marked
improvement with
thymectomy
(thymic hyper-
plasia)
No No R ovarian teratoma
Immunotherapy IVIg, Rx, Az IVIg, Mp, maintenance
IVIg
IVIg , Rx, Mp,
maintenance IVIg,
tumor removal
IVIg, Rx, thymectomy IVIg, Mycophenolate IVIg, Prednisone, Rx,
Mtx, Az
IVIg, IVMp, Rx,
tumor removal
History of psychiatric
admissions?
2 month admission
6.5 years pre-dx for tx
refractory psychosis
requiring ECT
No No Multiple psychiatric
admissions for
psychosis over
previous 6 years;
Initially tx with ECT
At least 4 psychiatric
admissions for
psychosis over
previous 15 – 20 years;
Initially tx with ECT
No, but initially tx for
psychosis in mental
health unit
No
Estimated time
between tx
initiation &
current ax
41 months 31 months 12 months 14 months 19 months 38 months 7 months
Estimated time
between tx
completion &
current ax
Tx ongoing at time of
testing – residual
symptoms
31 months 9 months Tx ongoing at time of
testing – residual
symptoms
Mycophenolate ongoing
at time of testing –
residual symptoms
35 months since acute
illness tx
completed;
Preventative Rx
ongoing
4 months
CSF/serum abs at dx CSF NT
Serum + ve
CSF + ve
Serum NT
CSF + ve
Serum + ve
CSF + ve
Serum + ve
CSF NT
Serum + ve
CSF + ve
Serum –ve
CSF + ve
Serum + ve
CSF/serum abs at
most recent FU
CSF NT
Serum + ve (same
intensity)
CSF NT
Serum NT
CSF NT
Serum –ve
CSF NT
Serum + ve (same
intensity)
CSF NT
Serum + ve (same
intensity)
CSF NT
Serum –ve
CSF NT
Serum NT
Subjective
complaints
Fatigue, anxiety,
memory, labile
emotions, sleep
disturbance,
intermittent
psychotic symptoms,
social withdrawal
Anxiety, weight gain,
personality changes,
altered menstrual
pattern, avoidance of
social situations
involving unfamiliar
people
Fatigue,
distractibility,
labile emotions
Sleep disturbance,
memory, labile
emotions
Fatigue, anxiety,
attention/
concentration,
memory, weight gain,
social withdrawal
Fatigue, anxiety,
memory, balance,
labile emotions
(when tired), social
withdrawal,
occasional failure
to recognize own
indiscretions
Fatigue, memory,
personality
changes, labile
emotions, slight
disinhibition,
occasional mis-
interpretation of
social situations
mRS 3 1 2 2 1 1 2
Subjective recovery
rating
5/10 6/10 7.5/10 8/10 7/10 8/10 8/10
Notes. + ve = positive; -ve = negative; ADLS = activities of daily living; ax = assessment; Az = azathioprine; CSF = cerebrospinal ﬂuid; dx = diagnosis; ECT = electro-convulsive therapy; F = female; IVIg =
intravenous immunoglobulin; M = male; Mp = methylprednisolone; mRS = modiﬁed Rankin Scale; Mtx = methotrexate; NT = not tested; pre-dx = pre-diagnosis; R = right; Rx = rituximab; tx = treat/ed/ment.
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reported everyday difﬁculties. Most described changes in
their social functioning, such as withdrawal, disinhibition,
misinterpreting interpersonal signals, or failing to recognize
their own indiscretions.
Neuropsychological Assessment Results
At the group-level (see Table 3), patient sample performance
fell signiﬁcantly below that of the control group in the
domains of verbal and visual episodic memory (logical
memory and verbal paired associates tasks, Rey complex
ﬁgure test), sustained attention (SART), divided attention
(PRP), information processing speed (color naming and word
reading tasks), verbal short-term and working memory (digit
span forward and backward), and executive functioning
(visual-spatial planning/organization and problem solving, as
assessed by the copy trial of the Rey complex ﬁgure test and
the Tower Test). Medium-to-large effect sizes were
identiﬁed.
Performance on tests of overall intellectual functioning
(FSIQ), perceptual reasoning (matrix reasoning), semantic
memory (vocabulary, Pyramids and Palm Trees Test,
semantic verbal ﬂuency), language (vocabulary, Graded
Naming Test, spontaneous speech, verbal ﬂuency), basic
psychomotor speed (motor speed, visual scanning and letter/
number sequencing tasks), and aspects of executive
functioning (abstraction, response inhibition, ﬂexibility, and
verbal ﬂuency, as assessed by the Trail Making Test, Hayling
Test, and the color-word interference, verbal ﬂuency, and
proverbs tasks) were comparable between groups. Estimated
premorbid intellect was signiﬁcantly higher in the control
sample, however, two patients reported longstanding
academic difﬁculties. Scores on a test of vocabulary, which is
less reliant on reading skills suggested performance equiva-
lence between groups with respect to premorbid intellect. The
patient sample reported signiﬁcantly higher levels of anxiety
relative to controls. Individually, greater variability in neuro-
psychological functioning was evident (see Supplementary
Material, which is available online).
Social Cognition Assessment Results
On the advanced ToM task, the groups were equivalent in
their understanding of social encounters and use of physical
information in their interpretations of these situations.
However, controls made a signiﬁcantly higher number of
references to mental state information (medium effect size).
Mental state interpretation capacity as assessed by the
Reading the Mind in the Eyes test did not differ signiﬁcantly
between groups. The patient and control groups accurately
identiﬁed social situations as normative and violations at
comparable rates. Relative to controls, the patient group rated
social violations as signiﬁcantly less severe (large effect
size). Once again, there was considerable individual varia-
bility in performance across tests of social cognition (see
online supplementary material).
Functional Outcomes
A range of functional levels were evident (see Table 2).
“Good” functional outcomes were recorded in six patients.
None achieved “full recovery,” with scores between 1 and 2
indicating “mild deﬁcits.” “Poor” outcomes were recorded
for P1. All believed recovery was occurring gradually, and
that assistance from family, friends, and employers/educators
was facilitating this process. Progress barriers included fear
of relapse, loss of conﬁdence and ongoing problems with
cognition and mental health.
DISCUSSION
To our knowledge, this is the ﬁrst exploratory investigation
of social cognition and the most comprehensive neu-
ropsychological evaluation of anti-NMDAR encephalitis
patients conducted to date. We sought to support the work of
Finke et al. (2012), and also aimed to validate preliminary
evidence that anti-NMDAR encephalitis adversely affects
social cognition (Bach, 2014). Given the small sample size
and large number of statistical comparisons that were applied
in the context of this preliminary investigation, results must
be interpreted cautiously.
Social Cognition
This study is the ﬁrst to document anti-NMDAR encephalitis
patient performance decrements on tests of social cognition.
Noteworthy differences in performance from controls related
to judging the severity of interpersonal violations, and using
mental state information to make sense of social situations.
Basic emotion attribution skills were relatively preserved, as
was capacity for recognizing normative and unconventional
social behavior, and accurately decoding mental state infor-
mation through facial features.
These ﬁndings are in keeping with reports of disturbed
interpersonal functioning during recovery from anti-
NMDAR encephalitis (Bach, 2014; Dalmau et al., 2011).
Results extend those described by Bach (2014). Speciﬁcally,
the current study reports subjective social dysfunction
experienced by patients can occur in conjunction with
objectively aberrant responses on measures of social cogni-
tion. Results suggested that anti-NMDAR encephalitis may
adversely affect the ability to decode and adaptively use
mental state information.
Neuropsychological Outcomes
Consistent with previous research in adult (Finke et al., 2012)
and pediatric samples (Matricardi et al., 2016), neuro-
psychological deﬁcits were identiﬁed in most patients despite
substantial clinical/functional recovery, and protracted
treatment duration. Patient group performance was affected
in the domains of verbal and visual episodic memory,
working memory, attention, information processing speed,
Anti-NMDAR encephalitis cognitive outcomes 833
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Table 3. Summary of performance on cognitive measures and questionnaire responses for anti-NMDAR encephalitis patient and control groups
Controls (n = 14) Patients (n = 7)
Cognitive domain/Task M (SD) M (SD) Test statistic and signiﬁcance Effect size (r)
Premorbid IQ
TOPF – Predicted FSIQ-2a 108.35 (9.36) 98.42 (8.26) U = 15.00, p< .011* 0.554
Current IQ
FSIQ-2a 109.71 (8.93) 102.57 (6.97) t(19) = −1.845, p = .081, ns 0.390
Matrix Reasoningb 22.71 (2.49) 20.57 (3.10) t(19) = −1.714, p = .103, ns 0.366
Vocabularyb 41.50 (3.83) 39.85 (2.67) t(19) = −1.011, p = .325, ns 0.226
Verbal Memory
WMS Story Recall: Immediate 31.71 (5.26) 23.57 (8.14) U = 16.50, p< .015* 0.532
Delayed 28.35 (5.95) 17.85 (8.61) t(19) = −3.285, p< .004** 0.602
Recognition 26.42 (1.78) 24.28 (5.31) U = 43.00, p = .650, ns 0.099
WMS Word Pair Recall: Immediate 45.85 (6.93) 31.14 (9.94) U = 9.00, p< .003** 0.652
Delayed 13.14 (1.23) 9.57 (3.10) U = 14.50, p< .008** 0.582
Recognition 39.78 (0.42) 37.85 (2.11) U = 13.00, p < .003** 0.659
Visual Memory
Rey Figure Recall: Immediate 25.39 (3.82) 17.28 (9.76) U = 27.00, p = .100, ns 0.359
Delayed 25.37 (3.48) 17.92 (11.21) U = 28.00, p = .117, ns 0.342
Recognition 21.35 (1.15) 19.85 (2.11) t(19) = −2.128, p< .047* 0.439
Semantic Memory
Pyramids & Palm Trees Test 50.35 (1.33) 49.85 (1.77) U = 43.50, p = .665, ns 0.095
Working Memory
Digit Span: Total 33.50 (5.52) 26.85 (2.91) t(19) = −2.954, p< .008** 0.561
Backwards 11.07 (2.70) 8.42 (1.27) t(19) = −2.433, p< .025* 0.487
Sequencing 10.78 (2.22) 9.14 (2.41) t(19) = −1.553, p = .137, ns 0.336
Language
Graded Naming Testb 19.85 (3.65) 18.00 (4.47) t(19) = −1.020, p = .320, ns 0.228
Spontaneous Speech: WPM 130.91 (19.94) 114.37 (24.59) t(19), = −1.660, p = .113 0.356
Utterances 12.21 (5.47) 9.57 (2.57) t(19) = −1.200, p = .245, ns 0.265
Visual-Spatial Organization
Rey Figure Copyb 34.92 (1.49) 33.42 (1.51) U = 20.00, p< .026* 0.486
Attention & Speed of Processing
Digit Span Forwards 11.64 (2.70) 9.28 (1.60) t(19) = −2.110, p< .048* 0.436
Visual Scanning Time 16.50 (3.89) 18.57 (2.87) t(19) = 1.241, p = .230, ns 0.274
Letter Sequencing Time 24.57 (8.71) 25.42 (13.80) U = 46.00, p = .823, ns 0.049
Number Sequencing Time 24.21 (6.51) 32.57 (18.50) U = 34.00, p = .262, ns 0.245
Motor Speed Time 26.07 (11.02) 27.57 (3.99) U = 32.50, p = .217, ns 0.269
Colour Naming Time 24.07 (4.00) 28.71 (5.05) t(19) = 2.297, p< .033* 0.466
Word Reading Time 18.92 (2.99) 22.85 (3.89) t(19) = 2.566, p< .019* 0.507
PRP Paradigm: Accuracy 1 0.95 (0.07) 0.96 (0.07) U = 37.50, p = .369, ns 0.196
Accuracy 2 0.95 (0.06) 0.92 (0.15) U = 44.50, p = .729, ns 0.076
T1 RT short SOA 0.93 (0.40) 1.15 (0.21) U = 21.00, p< .037* 0.456
T1 RT long SOA 1.09 (0.64) 1.64 (0.19) U = 20.00, p< .030* 0.472
T2 RT short SOA 1.11 (0.54) 1.39 (0.33) U = 21.00, p< .037* 0.456
T2 RT long SOA 0.85 (0.57) 1.15 (0.20) U = 20.00, p< .030* 0.472
SART: Commission Accuracy 0.63 (0.23) 0.76 (0.19) t(19) = 1.294, p = .211, ns 0.284
Commission RT 0.30 (0.10) 0.41 (0.25) U = 24.50, p = .067, ns 0.399
Omission Accuracy 0.97 (0.04) 0.94 (0.10) U = 34.50, p = .264, ns 0.244
Omission RT 0.40 (0.06) 0.48 (0.05) t(19) = 2.769, p< .012* 0.536
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Executive Functioning
Trail Making Test: Switching Time 59.64 (15.89) 65.57 (26.22) t(19) = .649, p = .524, ns 0.373
Switching Errors 0.78 (0.97) 0.14 (0.37) U = 30.00, p = .102, ns 0.357
Verbal Fluency: Letters 41.92 (9.34) 34.85 (8.27) t(19) = −1.694, p = .107, ns 0.362
Categoriesb 45.57 (8.90) 39.57 (7.72) t(19) = −1.516, p = .146, ns 0.328
Category Switching 14.50 (2.65) 13.71 (3.63) U = 45.00, p = .764, ns 0.066
Set-Loss Errors 1.14 (1.70) 2.42 (2.57) U = 31.00, p = .162, ns 0.305
Repetition Errors 1.85 (2.03) 2.14 (1.95) U = 42.00, p = .593, ns 0.117
Total Responses 105.00 (19.82) 92.71 (12.94) t(19) = −1.479, p = .155, ns 0.321
Inhibition Test (Stroop Test): Time 42.48 (8.83) 51.42 (13.69) t(19) = 1.861, p = .078, ns 0.393
Errors 1.00 (0.96) 2.28 (2.21) U = 32.50, p = .203, ns 0.278
Inhibition/ Switching Test: Time 51.42 (11.00) 54.28 (6.57) t(19) = .628, p = .537, ns 0.143
Errors 1.28 (1.48) 1.28 (1.11) U = 44.00, p = .694, ns 0.086
Tower Test: Achievement Score 17.28 (2.75) 16.28 (4.42) t(19) = − .640, p = .530, ns 0.145
Rule Violationsc 0.00 (0.00) 2.28 (4.78) χ2 (1) = 7.00, p< .026* 0.577
Proverbs Test: Achievement Score 25.78 (3.62) 25.14 (5.89) t(19) = − .311, p = .759, ns 0.071
Multiple-Choice Score 31.57 (1.60) 31.71 (0.75) U = 45.00, p = .558, ns 0.128
Hayling Test: Initiation RT 5.50 (3.58) 7.14 (6.20) t(19) = .775, p = .448, ns 0.175
Suppression RT 14.92 (18.34) 27.14 (21.96) t(19) = 1.349, p = .193, ns 0.296
Suppression Errors (A +B) 1.28 (1.06) 2.28 (1.79) U = 33.00, p = .220, ns 0.267
Overall Score 19.21 (1.47) 18.28 (0.95) U = 30.00, p = .125, ns 0.335
Social Cognition
Mind in the Eyes Test: Total Score 29.00 (3.03) 25.85 (5.24) t(19) = −1.753, p = .096, ns 0.373
Advanced ToM Test: Comprehension Score 14.28 (0.99) 13.28 (1.25) U = 25.00, p = .059, ns 0.413
Physical Information 2.14 (1.35) 2.57 (1.98) t(19) = .586, p = .565, ns 0.133
Mental State Information 14.07 (0.82) 12.85 (1.57) U = 23.00, p< .041* 0.446
Social Situations Test: Normative Correct 15.50 (1.78) 15.42 (1.27) U = 46.00, p = .819, ns 0.050
Violations Correct 19.14 (1.29) 17.00 (3.26) U = 31.00, p = .165, ns 0.303
Violation Severity Score 40.14 (5.64) 31.85 (9.06) t(19) = −2.591, p< .018* 0.511
Emotion Attribution Task: Happy Correct 15.00 (0.00) 14.85 (0.37) U = 42.00, p = .157, ns 0.309
Sad Correct 11.42 (2.13) 12.42 (2.22) t(19) = .997, p = .331, ns 0.223
Angry Correct 10.85 (2.71) 10.14 (2.34) t(19) = − .593, p = .560 ns 0.135
Fearful Correct 14.00 (0.78) 14.57 (0.53) U = 29.00, p = .108, ns 0.351
Embarrassed Correct 12.07 (2.23) 10.28 (4.34) U = 35.50, p = .308, ns 0.223
Total Correct 63.35 (4.10) 62.28 (3.63) t(19) = − .584, p = .566, ns 0.133
Psychological Health
HADS Anxiety 5.35 (3.87) 8.71 (2.13) t(19) = 2.119, p< .048* 0.437
HADS Depression 1.78 (1.47) 3.85 (4.01) U = 36.00, p = .303, ns 0.225
Notes. HADS = Hospital Anxiety and Depression Scale; FSIQ-2 = Full Scale Intelligence Quotient, 2 subtest version; M = mean; n.s. = not signiﬁcant; PRP = Psychological Refractory Period; RT = Reaction
Time; SART = Sustained Attention to Response Task; SD = standard deviation; SOA = Stimulus Onset Asynchrony; T1 = Target 1; T2 = Target 2; ToM = Theory of Mind; TOPF = Test of Premorbid
Functioning; WMS = Wechsler Memory Scale; WPM = words per minute.
*p< .05, **p< .01, two-tailed.
aStandardized score (all other analyses conducted on raw data).
bMeasure taps multiple domains.
cAnalyzed as dichotomous variable through Chi-Square (errors vs. no errors).
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and executive functioning. Episodic memory and aspects of
executive functioning represented the most severely affected
abilities at the individual level; however, proﬁles ranged from
within normal limits to extensive dysfunction.
By contrast, psychomotor speed, semantic memory,
perceptual reasoning, language, and general intellectual
functions were relatively preserved. It has recently been
reported that structural hippocampal damage and associated
memory deﬁcits represent long-term sequelae of anti-NMDAR
encephalitis (Finke et al., 2015). This is interesting in view of
our ﬁnding that patient performance on tests of episodic
and semantic memory suggested that episodic memory
ability was preferentially affected over semantic memory
ability during recovery from anti-NMDAR encephalitis. With
respect to executive functioning, results highlighted that
patients varied quite substantially with respect to their perfor-
mance in this domain, and that component skills’ weaknesses
need to be evaluated on a case-by-case basis.
Our ﬁndings are congruent with the distribution and roles of
the NMDAR system, and underlying pathogenic mechanisms
whereby antibodies diminish NMDAR-mediated synaptic
function (Hughes et al., 2010; Moscato et al., 2010, 2013).
Nonetheless, the spectrum of individual proﬁles and absence of
abnormal MRI ﬁndings is in keeping with disorder complexity,
and evidence that neurological sequelae are best considered
from a functional perspective (Dalmau et al., 2011; Finke et al.,
2013; Iizuka et al., 2010).
Mental Health and General Functioning
Our results suggested that anti-NMDAR encephalitis patients
often experience anxiety and depression during recovery.
Nonetheless, most were making excellent progress toward
baseline functional status, despite mild deﬁcits. However, loss
of conﬁdence had prompted several patients to re-evaluate
employment and educational pathways. This was potentially
unnecessary in at least two cases, highlighting that recovering
patients may beneﬁt from psychological interventions.
Research and Clinical Implications
There is now accumulating evidence that anti-NMDAR
encephalitis patients require formal assessment for residual
cognitive dysfunction, with individually tailored rehabilitation
interventions developed where indicated. Resolution of gross
neurological and psychotic symptoms is not an adequate
treatment goal. Clinicians are advised not to underestimate
difﬁculties in social and vocational functioning, and
psychological health. This seems particularly important given
the young age of many patients.
Additional research is required to support the novel
claim that anti-NMDAR encephalitis patients demonstrate
impairment on tests of social cognition. These deﬁcits
potentially account for the observation that social behavior is
slow to improve (Dalmau et al., 2011; Tham & Kong, 2012).
The neurological mechanisms associated with memory
dysfunction in this population have been investigated in recent
research (Finke et al., 2013, 2015). Additional studies
of this nature could elucidate the functional neurological
correlates of other neuropsychological deﬁcits, including
social cognition. Intervention trials aimed at improving ToM
such as Social Cognition and Interaction Training (Lahera
et al., 2013; Penn, Roberts, Combs, & Sterne, 2007; Roberts &
Penn, 2009) could determine if these deﬁcits are reversible.
Addressing this aspect of patient care seems important given
the possibility that disease mechanisms may interrupt social
skills development.
This study suggests recovery occurs gradually, although not
necessarily in a linear fashion. Neuropsychological deﬁcits were
observed up to several years following the initiation (and in
some cases completion) of adequate treatment, indicating the
course of cognitive dysfunction can be protracted. Our results
also suggest that cognitive impairments in treated anti-NMDAR
encephalitis patients may occur as a consequence of ongoing
residual disease activity in combination with more chronic
illness sequelae. Small sample size and low power prevented
meaningful analysis of clinical variables associated with
neuropsychological outcomes. However, previous research
(Finke et al., 2012; Matricardi et al., 2016) has suggested that
early and aggressive immunotherapy may be relevant to more
favorable cognitive outcomes in this population.
This study identiﬁed heterogeneity in neuropsychological
performance in this sample, with proﬁles ranging from
pervasive impairments to normal functioning across all domains
assessed. Findings indicate the utility of comprehensive baseline
assessments, with particular focus on episodic memory,
executive functioning, attention, information processing speed,
and working memory. Within domains multiple measures
are recommended to accurately characterize deﬁcits. Serial
neuropsychological testing may have utility for monitoring
disease activity, as has been suggested by previous research
(Finke et al., 2012).
SUMMARY AND CONCLUSIONS
Despite small patient numbers inevitable in a rare and recently
characterized disorder, this study demonstrated that cognitive
deﬁcits and impairments of social cognition associated
with anti-NMDAR encephalitis can persist for many years
following the initiation of adequate treatment. The spectrum of
neuropsychological functioning ranged from an absence
of deﬁcits to more extensive dysfunction. Performance
decrements were identiﬁed in several cognitive domains,
including episodic memory, executive functioning, working
memory, attention, and information processing speed.
This study is the ﬁrst to corroborate anecdotal reports that
social cognition may function abnormally during recovery
from anti-NMDAR encephalitis. It is recommended that future
studies involving larger samples and longitudinal assessments
are conducted. Such research could contribute greater clarity
regarding the course of cognitive dysfunction in anti-NMDAR
encephalitis, and factors related to neuropsychological
outcomes in this population.
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